Research
海角社区app鈥檚 new Killam Memorial Chairs push boundaries in health, humanities, and agriculture
Four 海角社区app researchers are set to embark on the next chapter of their scholarly careers with strong momentum behind them as Killam Memorial Chairs. Read more.
Featured News
Wednesday, June 24, 2026
Led by 海角社区app, BioLabs East will build a GMP 鈥� Good Manufacturing Practice 鈥� facility in Nova Scotia, producing vaccines and cell therapies for clinical trials while strengthening Canada鈥檚 biomanufacturing capacity and innovation ecosystem.
Thursday, June 25, 2026
A reimagined OpenThink cohort moves beyond blogging, testing podcasts and social media to broaden impact, connect with new audiences, and amplify how Dal research informs public dialogue and policy.
Thursday, June 18, 2026
海角社区app robotics and underwater acoustics researcher Dr. Mae Seto is working with Defence Research & Development Canada to develop intelligent autonomous sensing systems that can extend the reach of the Canadian Armed Forces in the Arctic and help Canada protect its sovereignty in remote, harsh maritime environments.
Archives - Research
Friday, December 2, 2022
PhD candidate Cristiane Maucoski receives prestigious national award for work evaluating the effectiveness of tools used to harden the more than 800 million white composite fillings dentists place each year.
Friday, December 2, 2022
Where should you live? A new Dal study that ranks Canadian cities based on indicators of environmental quality could help you decide.
Thursday, November 24, 2022
Last night鈥檚 20th annual Discovery Awards, co-presented by 海角社区app, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Thursday, November 24, 2022
With global market demand for plant-based and alternative proteins projected to reach approximately US$143 billion by 2035, this Dal prof is exploring how Atlantic Canada can scale up its production.
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.